Medications associated with increased fall risk in older adults — particularly benzodiazepines (lorazepam, alprazolam, etc.), sleep medications (zolpidem), opioids, anticholinergics (diphenhydramine, oxybutynin), and some antidepressants. The Beers Criteria, published by the American Geriatrics Society, is the standard reference.
What it means in practice
Falls are the leading cause of injury death in adults 65+. About 1 in 4 older adults falls each year; 1 in 5 falls causes serious injury. Medications are a substantial, modifiable contributor — usually estimated to be implicated in 20-40% of falls in older adults.
The Beers Criteria (American Geriatrics Society, updated regularly; current 2023 edition) is the standard reference for "potentially inappropriate medications" in adults 65+. It lists drugs with elevated risk-benefit ratios in this population, organized by drug class. Always-avoid categories include first-generation antihistamines (Benadryl, hydroxyzine), barbiturates, meprobamate, and certain antipsychotics outside specific indications.
Highest-risk medication classes for falls specifically:
• **Benzodiazepines** (lorazepam/Ativan, alprazolam/Xanax, clonazepam/Klonopin, diazepam/Valium) — sedation + impaired balance + impaired judgment
• **Z-drugs (sleep medications)** (zolpidem/Ambien, eszopiclone/Lunesta, zaleplon/Sonata) — middle-of-night falls are common
• **Opioids** (oxycodone, hydrocodone, tramadol, morphine, fentanyl) — sedation + dizziness + constipation that drives bathroom trips
• **Anticholinergics**: first-generation antihistamines (Benadryl), tricyclic antidepressants (amitriptyline, nortriptyline), oxybutynin (for bladder), some antipsychotics — cognitive impairment + blurred vision + orthostatic hypotension
• **Some antidepressants**: TCAs (above) more than SSRIs; even SSRIs increase fall risk modestly
• **Antipsychotics** (haloperidol, risperidone, quetiapine) — often prescribed off-label for dementia behavioral symptoms; FDA black-box warning for increased mortality in dementia + significant fall risk
• **Cardiovascular medications causing orthostatic hypotension**: alpha-blockers (terazosin, doxazosin), some diuretics, vasodilators
• **Anticonvulsants**: gabapentin, pregabalin — increasingly prescribed for off-label uses; cause dizziness, sedation, balance problems
Deprescribing strategy:
• Annual medication review with the PCP or pharmacist, ideally with the Beers Criteria in hand
• Identify which fall-risk medications are still serving a clear purpose and which can be tapered
• Consider non-pharmacological alternatives for sleep (sleep hygiene, melatonin, CBT-I), anxiety (therapy, behavioral approaches), chronic pain (PT, TENS, topical agents)
• Taper benzodiazepines and Z-drugs SLOWLY (over weeks to months) — abrupt discontinuation causes withdrawal seizures + rebound anxiety
• Consider Apple Watch / iPhone fall detection or a medical alert device for patients on multiple fall-risk medications
• Home safety audit (grab bars, removed throw rugs, lit pathways, raised toilet seat) — the medications + the environment together drive fall risk
For families: maintaining the medication list in Kintaria, flagging fall-risk medications, and bringing it to each provider visit lets you start the deprescribing conversation specifically. "I notice mom is on lorazepam — is this still needed?" is a more actionable opening than "she's on too many medications."